BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9614620)

  • 1. Apolipoprotein E polymorphism and renal function in German type 1 and type 2 diabetic patients.
    Werle E; Fiehn W; Hasslacher C
    Diabetes Care; 1998 Jun; 21(6):994-8. PubMed ID: 9614620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein E2, renal failure and lipid abnormalities in non-insulin-dependent diabetes mellitus.
    Horita K; Eto M; Makino I
    Atherosclerosis; 1994 Jun; 107(2):203-11. PubMed ID: 7980694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Association study of apolipoprotein e gene polymorphism and cerebral infarction in type 2 diabetic patients].
    Zhou J; Xue YL; Guan YX; Yang YD; Fu SB; Zhang JC
    Yi Chuan; 2005 Jan; 27(1):35-8. PubMed ID: 15730956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reciprocal effects of apolipoprotein E alleles (epsilon 2 and epsilon 4) on plasma lipid levels in normolipidemic subjects.
    Eto M; Watanabe K; Ishii K
    Clin Genet; 1986 Jun; 29(6):477-84. PubMed ID: 3461894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E genotype is a determinant of low-density lipoprotein cholesterol and of its response to a low-cholesterol diet in Type 1 diabetic patients with elevated urinary albumin excretion.
    Blaauwwiekel EE; Beusekamp BJ; Sluiter WJ; Hoogenberg K; Dullaart RP
    Diabet Med; 1998 Dec; 15(12):1031-5. PubMed ID: 9868977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipids, lipoproteins, antioxidants and glomerular and tubular dysfunction in type 1 diabetes.
    O'Brien SF; Watts GF; Powrie JK; Shaw KM; Miller NJ
    Diabetes Res Clin Pract; 1996 Apr; 32(1-2):81-90. PubMed ID: 8803485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fish oil in diabetic nephropathy.
    Rossing P; Hansen BV; Nielsen FS; Myrup B; Hølmer G; Parving HH
    Diabetes Care; 1996 Nov; 19(11):1214-9. PubMed ID: 8908382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of apolipoprotein E genotype on the reliability of the Friedewald formula in the estimation of low-density lipoprotein cholesterol concentrations.
    Tremblay AJ; Bergeron J; Gagné JM; Gagné C; Couture P
    Metabolism; 2005 Aug; 54(8):1014-9. PubMed ID: 16092050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of apolipoprotein E gene polymorphism with ischemic stroke involving large-vessel disease and its relation to serum lipid levels.
    Saidi S; Slamia LB; Ammou SB; Mahjoub T; Almawi WY
    J Stroke Cerebrovasc Dis; 2007; 16(4):160-6. PubMed ID: 17689412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between apolipoprotein E polymorphism and macroalbuminuria in patients with non-insulin dependent diabetes mellitus.
    Ha SK; Park HS; Kim KW; Kim SJ; Kim DH; Kim JH; Lee HY; Han DS
    Nephrol Dial Transplant; 1999 Sep; 14(9):2144-9. PubMed ID: 10489223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between lipoprotein(a) and insulin-like growth factor I during puberty and the relationship to microalbuminuria in children and adolescents with IDDM.
    Rudberg S; Persson B
    Diabetes Care; 1995 Jul; 18(7):933-9. PubMed ID: 7555552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between apolipoprotein E polymorphism and subclinic atherosclerosis in patients with type 1 diabetes mellitus.
    Atabek ME; Özkul Y; Eklioğlu BS; Kurtoğlu S; Baykara M
    J Clin Res Pediatr Endocrinol; 2012 Mar; 4(1):8-13. PubMed ID: 22394699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between apolipoprotein E genetic polymorphism and the development of diabetic nephropathy in type 2 diabetic patients.
    Kwon MK; Rhee SY; Chon S; Oh S; Woo JT; Kim SW; Kim JW; Kim YS; Jeong KH; Lee SH; Lee TW; Ihm CG
    Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S228-32. PubMed ID: 17624465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of apolipoprotein E gene polymorphism to serum lipid concentrations in healthy Thais.
    Chanprasertyothin S; Ongphiphadhanakul B; Rajatanavin R; Piaseu N; Chailurkit LO; Puavilai G
    J Med Assoc Thai; 2000 Oct; 83(10):1233-9. PubMed ID: 11143490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased plasma apolipoprotein (a) levels in IDDM patients with diabetic nephropathy.
    Tarnow L; Rossing P; Nielsen FS; Hansen BV; Dyerberg J; Parving HH
    Diabetes Care; 1996 Dec; 19(12):1382-7. PubMed ID: 8941468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-converting enzyme insertion/deletion polymorphism and diabetic albuminuria in patients with NIDDM followed Up for 9 years.
    Huang XH; Rantalaiho V; Wirta O; Pasternack A; Hiltunen TP; Koivula T; Malminiemi K; Nikkari T; Lehtimäki T
    Nephron; 1998 Sep; 80(1):17-24. PubMed ID: 9730698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein E polymorphism in diabetic and non-diabetic patients: does it really contribute to atherosclerosis?
    Camsari A; Tamer L; Aras Ateş N; Pekdemir H; Ciçek D; Ercan B; Camdeviren H; Atik U
    Acta Cardiol; 2005 Aug; 60(4):409-14. PubMed ID: 16128374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased frequency of apolipoprotein epsilon 2 allele in non-insulin dependent diabetic (NIDDM) patients with nephropathy.
    Eto M; Horita K; Morikawa A; Nakata H; Okada M; Saito M; Nomura M; Abiko A; Iwashima Y; Ikoda A
    Clin Genet; 1995 Dec; 48(6):288-92. PubMed ID: 8835322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of relationship in long-term type 1 diabetic patients between diabetic nephropathy and polymorphisms in apolipoprotein epsilon, lipoprotein lipase and cholesteryl ester transfer protein. Genétique de la Nephropathie Diabétique Study Group. Données Epidémiologiques sur le Syndrome d'Insulino-Résistance Study Group.
    Hadjadj S; Gallois Y; Simard G; Bouhanick B; Passa P; Grimaldi A; Drouin P; Tichet J; Marre M
    Nephrol Dial Transplant; 2000 Dec; 15(12):1971-6. PubMed ID: 11096142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Albumin excretion rate levels in non-diabetic offspring of NIDDM patients with and without nephropathy.
    Gruden G; Cavallo-Perin P; Olivetti C; Repetti E; Sivieri R; Bruno A; Pagano G
    Diabetologia; 1995 Oct; 38(10):1218-22. PubMed ID: 8690175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.